Form 4: Recursion Pharma CEO's Routine Tax-Related Stock Disposition

Recursion Pharmaceuticals CEO Najat Khan disposed of 14,280 shares of Class A Common Stock to cover tax obligations related to restricted stock units.

Summary

• Najat Khan, CEO and President of Recursion Pharmaceuticals, Inc. (RXRX), reported a disposition of 14,280 shares of Class A Common Stock.
• The transaction occurred on February 17, 2026, at a price of $3.49 per share.
• This disposition was a tax-related withholding by the issuer to satisfy tax obligations arising from the net settlement of restricted stock units.
• Following this transaction, Khan directly beneficially owns 2,290,383 shares of Class A Common Stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, representing a standard tax-related transaction for executive equity compensation rather than a discretionary sale or purchase that would indicate a change in sentiment.

Positives

• The transaction represents a routine administrative event for an executive to cover tax liabilities associated with equity compensation, indicating standard corporate compensation practices.

Negatives

• The disposition of shares, while routine, reduces the executive's direct ownership, though it is not a discretionary sale.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

StockSavvy.ai notes that routine insider transactions like tax-related dispositions are common for executives receiving equity compensation and typically do not signal changes in company fundamentals or strategy. This event is a standard administrative process for managing executive compensation.

Comparison to Industry Standards

• This type of transaction, where shares are withheld to cover tax obligations upon the vesting or settlement of restricted stock units, is a standard practice across industries for executives receiving equity-based compensation. It aligns with common compensation and tax management protocols for publicly traded companies.

Related Party Transactions

• The disposition of shares by CEO Najat Khan to the issuer for tax withholding purposes is a routine related-party transaction associated with executive compensation.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine, non-discretionary transaction for tax purposes, not a strategic sale.

Key Dates

Recommendation

This Form 4 reports a routine tax-related disposition of shares by an executive, which is a common occurrence with equity compensation. It does not indicate a change in the company's fundamentals or the executive's confidence, thus a 'hold' recommendation is appropriate based solely on this filing.

Keywords

Recursion Pharmaceuticals, RXRX, Najat Khan, Form 4, insider transaction, stock disposition, tax withholding, restricted stock units, CEO